Clinical Trial Update: EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing EC-THP versus TCbHP in HER2-positive, lymph node–positive, early breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• EC-THP
• TCbHP

Snippet

Sponsor: Fudan University | Conditions: HER2 Positive Early Breast Cancer | Phase 3 | Status: RECRUITING